Atlas Trials

Comparing 123I-MIBG and 18F-MFBG Imaging in Patients With Newly Diagnosed, High Risk Neuroblastoma

Clinical trial NCT06858501 · NOT_YET_RECRUITING

Trial details

NCT number
NCT06858501
Sponsor
Children's Oncology Group
Status
NOT_YET_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
GanglioneuroblastomaGanglioneuroblastoma, NodularHigh Risk Neuroblastoma
Start date
2026-09-22
Primary completion
2028-12-20
Enrollment
84

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.